Debajit Roy, MD
Cardiovascular Disease · Glen Burnie, MDNPI 1952315673
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Amgen at 37.8% of the total. Reporting peaked in 2019 at $373 and has fallen 87.0% since, to $48 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in MD, where the typical reported total is $1,418.
Across 38 payments — averaging $20.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$288
- Johnson & Johnson$99
- Medtronic$90
- Preventice Services, LLC$81
- Pfizer$74
- Novartis$40
- plus $88 from 4 others
What the payments were for
- Food & beverage$761100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 16 | $288 |
| Johnson & Johnson | 6 | $99 |
| Medtronic(2 entities) | 2 | $90 |
| Preventice Services, LLC | 1 | $81 |
| Pfizer | 5 | $74 |
| Novartis | 3 | $40 |
| Abbott | 2 | $36 |
| Boehringer Ingelheim | 1 | $29 |
| Amarin Pharma, Inc. | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $5 |
How this compares
$761 in reported general payments places this provider in the 40th percentile of 507 cardiovascular disease providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Glen Burnie
- Bassim BadroGlen Burnie$14K
- Navin KapurBaltimore$1.5M
- Michael BlahaBaltimore$609K
- Sanjay RajagopalanBaltimore$521K
- Allen TaylorN Bethesda$456K
- David GoorayLargo$333K
- Erin MichosBaltimore$257K
- Seth MartinBaltimore$166K
- Erika FellerBaltimore$121K
- Mark HaigneyBethesda$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.